Glutamate acts on acid-sensing ion channels to worsen ischaemic brain injury

Abstract Glutamate is traditionally viewed as the first messenger to activate NMDAR ( N -methyl- d -aspartate receptor)-dependent cell death pathways in stroke 1,2 , but unsuccessful clinical trials with NMDAR antagonists implicate the engagement of other mechanisms 3–7 . Here we show that glutamate and its structural analogues, including NMDAR antagonist l -AP5 (also known as APV), robustly potentiate currents mediated by acid-sensing ion channels (ASICs) associated with acidosis-induced neurotoxicity in stroke 4 . Glutamate increases the affinity of ASICs for protons and their open probability, aggravating ischaemic neurotoxicity in both in vitro and in vivo models. Site-directed mutagenesis, structure-based modelling and functional assays reveal a bona fide glutamate-binding cavity in the extracellular domain of ASIC1a. Computational drug screening identified a small molecule, LK-2, that binds to this cavity and abolishes glutamate-dependent potentiation of ASIC currents but spares NMDARs. LK-2 reduces the infarct volume and improves sensorimotor recovery in a mouse model of ischaemic stroke, reminiscent of that seen in mice with Asic1a knockout or knockout of other cation channels 4–7 . We conclude that glutamate functions as a positive allosteric modulator for ASICs to exacerbate neurotoxicity, and preferential targeting of the glutamate-binding site on ASICs over that on NMDARs may be strategized for developing stroke therapeutics lacking the psychotic side effects of NMDAR antagonists.